Teva Pharmaceuticals USA is recalling 112,327 bottles of Metoprolol Succinate Extended-Release Tablets in 25 mg, 50 mg, 100 mg, and 200 mg strengths. The recall was initiated because the medication failed to meet dissolution specifications, which means the drug may not release properly into the body. This generic version of Toprol-XL is used to treat high blood pressure, chest pain (angina), and heart failure.
If the tablets do not dissolve at the required rate, the medication may release too slowly or too quickly, potentially leading to ineffective treatment of blood pressure or heart conditions, or an increased risk of side effects.
You have 2 options:
100 and 1,000 tablet bottles; Recall #: D-0354-2026; Quantity: 18,780 bottles
100 and 1,000 tablet bottles; Recall #: D-0355-2026; Quantity: 67,043 bottles
100 and 1,000 tablet bottles; Recall #: D-0356-2026; Quantity: 7,448 bottles
100 tablet bottles; Recall #: D-0357-2026; Quantity: 19,056 bottles
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.